The image guided surgery devices market has seen considerable growth due to a variety of factors.
•The market size for image guided surgery devices has seen significant expansion in the last few years. From $8.87 billion in 2024, it is projected to increase to $9.78 billion in 2025, posting a compound annual growth rate (CAGR) of 10.3%.
A number of factors have contributed to this historic period of growth, including an increase in chronic diseases, more extensive applications, developments in healthcare infrastructure, greater awareness among healthcare professionals, as well as regulatory support and approvals.
The image guided surgery devices market is expected to maintain its strong growth trajectory in upcoming years.
• Anticipations suggest a swift escalation in the size of the image guided surgery devices market over the forthcoming years, culminating to an estimated worth of "$15.78 billion by 2029 with a compound annual growth rate (CAGR) of 12.7%.
Several contributing factors for this projected growth include expansion of the market in developing economies, patient inclination towards less invasive medical procedures, treatment customization, global health scenarios and readiness, along with joint ventures and collaborations. The forecast period is also likely to witness ongoing technological advancements, integration of artificial intelligence, development in technology, global market expansion, and an increased adoption of robotics in the field.
The surge in neurological disorders is anticipated to boost the expansion of the image guided surgery devices market in the future. Neurological disorders refer to diseases impacting the central and peripheral nervous systems. Image-guided surgical equipment is employed to execute minimally invasive operations for treating neurological issues like brain tumors, or to carry out brain biopsies. For instance, as reported by the European Academy of Neurology, an Austrian non-profit medical society in May 2022, 1 in 3 individuals will be affected by a neurological illness at some point in their lives, and deaths due to neurological conditions have seen an almost 40% increment in the past three decades. Additionally, The European Academy of Neurology, a non-profit organization based in Europe, stated in May 2022 that a neurological disease will impact 1 in 3 individuals at some point. Thus, the growing prevalence of neurological disorders is propelling the development of the image guided surgery devices market.
The image guided surgery devices market covered in this report is segmented –
1) By Product: Image Guided Surgery Devices, Image Guided Surgery Software
2) By Device Type: CT, Ultrasound, MRI, X-Ray, Fluoroscopy, Endoscopes, PET, SPECT,
3) By Application: Cardiac Surgery, Neurosurgery, Orthopedic Surgery, Urology, Oncology Surgery, Gastroenterology, Other Applications
4) By End User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Research And Academic Institutions
Subsegments:
1) By Image Guided Surgery Devices: Optical Tracking Systems, Electromagnetic Tracking Systems, Ultrasound-Based Systems
2) By Image Guided Surgery Software: Pre-Operative Planning Software, Intra-Operative Imaging Software, Post-Operative Analysis Software
A significant trend in the image guided surgery devices market is the progress in technology. Leading market entities involved in the image guided surgery devices market are focusing on unveiling novel and cutting-edge technologies to fortify their market standing. Take for example, in March 2022, Siemens Healthineers, a medical device firm based out of Germany, launched their latest innovation, the MAGNETOM Free. Star and NAEOTOM Alpha. The MAGNETOM Free. Star is a scanner that doesn't require helium and has a very compact structure making its installation much easier. The device uses the new and unique DryCool technology, that decomplexifies MRI technologies and employs digitalization and artificial intelligence (AI) to provide high-quality MRI scan results. The NAEOTOM Alpha delivers high-definition images by using the lowest possible dose, providing spectrum information with every scan, and improvising contrast to reduce noise using its pioneer QuantaMax detector for direct signal conversion. Sectors such as cardiology, pulmonology, oncology, and emergency medicine diagnostics will witness advancements with the photon-counting CT's advent towards accurate, non-invasive diagnosis.
Major companies operating in the image guided surgery devices market include:
• General Electric Company
• Medtronic Plc.
• Olympus Corporation
• Siemens Healthineers
• Koninklijke Philips N.V.
• Brainlab AG
• Karl Storz Gmbh & Co. KG
• Stryker Corporation
• Varian Medical Systems Inc.
• Hitachi Medical Corporation
• Analogic Corporation
• Zimmer Biomet Holdings Inc.
• Smith and Nephew Plc
• FUJIFILM Holdings Corporation
• Shimadzu Corporation
• Intuitive Surgical Inc.
• Canon Medical Systems Corporation
• Synaptive Medical
• Accuray Incorporated
• ClaroNav Inc.
• Merge Healthcare Inc.
• CureMetric Health Tech
• Mirada Medical Ltd.
• Elekta AB
• XION GmbH
• Northern Digital Inc.
• Fiagon AG Medical Technologies
North America was the largest region in the image guided surgery devices market in 2024. The regions covered in the image guided surgery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa